Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic propofol injection versus Diprivan in healthy Chinese men
ChiCTR-TTRCC-12002260Phase 2Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of propofol (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Plasma propofol concentration. Started May 2011; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on ChiCTR-TTRCC-12002260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-12002260.